$AMS
AMERICAN SHARED HOSPITAL SERVICES

2016 Q2 Form 10-Q Financial Statement

#000114420416118323 Filed on August 11, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q4 2015 Q2
Revenue $4.518M $4.160M $4.394M
YoY Change 2.82% 4.26% 30.04%
Cost Of Revenue $2.679M $2.300M $2.592M
YoY Change 3.36% -6.12% 2.29%
Gross Profit $1.839M $1.860M $1.802M
YoY Change 2.05% 20.78% 113.25%
Gross Profit Margin 40.7% 44.71% 41.01%
Selling, General & Admin $960.0K $790.0K $979.0K
YoY Change -1.94% -5.95% 4.48%
% of Gross Profit 52.2% 42.47% 54.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.660M $1.530M $1.600M
YoY Change 3.75% -2.55% -0.62%
% of Gross Profit 90.27% 82.26% 88.79%
Operating Expenses $970.0K $790.0K $979.0K
YoY Change -0.92% -5.95% 4.48%
Operating Profit $443.0K $1.070M $478.0K
YoY Change -7.32% 52.86% -179.4%
Interest Expense $433.0K -$340.0K $345.0K
YoY Change 25.51% 9.68% -32.35%
% of Operating Profit 97.74% -31.78% 72.18%
Other Income/Expense, Net
YoY Change
Pretax Income $446.0K $710.0K -$1.631M
YoY Change -127.35% 82.05% 59.59%
Income Tax $93.00K $110.0K $106.0K
% Of Pretax Income 20.85% 15.49%
Net Earnings $93.00K $280.0K -$1.970M
YoY Change -104.72% 366.67% 112.51%
Net Earnings / Revenue 2.06% 6.73% -44.83%
Basic Earnings Per Share $0.02 -$0.36
Diluted Earnings Per Share $0.02 $49.82K -$0.36
COMMON SHARES
Basic Shares Outstanding 5.552M shares 5.364M shares 5.484M shares
Diluted Shares Outstanding 5.568M shares 5.484M shares

Balance Sheet

Concept 2016 Q2 2015 Q4 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.760M $2.210M $1.800M
YoY Change -2.22% -78.03% -81.89%
Cash & Equivalents $1.764M $2.209M $1.798M
Short-Term Investments $0.00
Other Short-Term Assets $850.0K $650.0K $860.0K
YoY Change -1.16% -25.29% -9.47%
Inventory
Prepaid Expenses
Receivables $3.840M $3.038M $3.654M
Other Receivables $70.00K $107.0K $123.0K
Total Short-Term Assets $6.530M $5.974M $6.431M
YoY Change 1.54% -58.07% -58.16%
LONG-TERM ASSETS
Property, Plant & Equipment $51.80M $47.12M $49.43M
YoY Change 4.79% -5.82% 6.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $579.0K $579.0K $600.0K
YoY Change -3.5% -78.63% -77.78%
Other Assets $395.0K $405.0K $466.0K
YoY Change -15.24% -24.44% -40.26%
Total Long-Term Assets $52.77M $48.14M $50.50M
YoY Change 4.5% -9.65% 1.22%
TOTAL ASSETS
Total Short-Term Assets $6.530M $5.974M $6.431M
Total Long-Term Assets $52.77M $48.14M $50.50M
Total Assets $59.30M $54.11M $56.93M
YoY Change 4.17% -19.86% -12.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.0K $375.0K $289.0K
YoY Change -23.88% -10.93% -50.17%
Accrued Expenses $1.640M $1.320M $1.460M
YoY Change 12.33% 40.43% -12.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $7.720M $2.674M $2.848M
YoY Change 171.07% 33.37% -59.14%
Total Short-Term Liabilities $9.580M $8.698M $8.902M
YoY Change 7.62% -46.48% -49.39%
LONG-TERM LIABILITIES
Long-Term Debt $19.79M $16.11M $19.16M
YoY Change 3.29% -22.47% 0.26%
Other Long-Term Liabilities $660.0K $720.0K $780.0K
YoY Change -15.38% -17.24%
Total Long-Term Liabilities $20.45M $16.83M $19.94M
YoY Change 2.56% -22.26% 4.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.580M $8.698M $8.902M
Total Long-Term Liabilities $20.45M $16.83M $19.94M
Total Liabilities $38.91M $33.98M $37.25M
YoY Change 4.46% 75.42% -16.48%
SHAREHOLDERS EQUITY
Retained Earnings $4.164M $4.020M $3.700M
YoY Change 12.54% -27.46%
Common Stock $16.11M $15.98M
YoY Change 1.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.39M $20.13M $19.68M
YoY Change
Total Liabilities & Shareholders Equity $59.30M $54.11M $56.93M
YoY Change 4.17% -19.86% -12.77%

Cashflow Statement

Concept 2016 Q2 2015 Q4 2015 Q2
OPERATING ACTIVITIES
Net Income $93.00K $280.0K -$1.970M
YoY Change -104.72% 366.67% 112.51%
Depreciation, Depletion And Amortization $1.660M $1.530M $1.600M
YoY Change 3.75% -2.55% -0.62%
Cash From Operating Activities $1.680M $2.390M $2.540M
YoY Change -33.86% 1.27% 156.57%
INVESTING ACTIVITIES
Capital Expenditures -$250.0K -$400.0K -$1.150M
YoY Change -78.26% -91.79% 666.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$10.00K
YoY Change -100.0% -101.3%
Cash From Investing Activities -$250.0K -$400.0K -$1.160M
YoY Change -78.45% -91.8% -287.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.810M -1.960M -510.0K
YoY Change 254.9% -190.32% -68.71%
NET CHANGE
Cash From Operating Activities 1.680M 2.390M 2.540M
Cash From Investing Activities -250.0K -400.0K -1.160M
Cash From Financing Activities -1.810M -1.960M -510.0K
Net Change In Cash -380.0K 30.00K 870.0K
YoY Change -143.68% -108.57% -4450.0%
FREE CASH FLOW
Cash From Operating Activities $1.680M $2.390M $2.540M
Capital Expenditures -$250.0K -$400.0K -$1.150M
Free Cash Flow $1.930M $2.790M $3.690M
YoY Change -47.7% -61.41% 223.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 ams Deposits And Construction In Progress Gross
DepositsAndConstructionInProgressGross
10796000 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50883000 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51800000 USD
CY2016Q2 us-gaap Assets
Assets
59301000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
395000 USD
CY2016Q2 ams Deposits And Construction In Progress Gross
DepositsAndConstructionInProgressGross
6892000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
405000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47123000 USD
CY2015Q4 us-gaap Assets
Assets
54114000 USD
CY2016Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
95069000 USD
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
83267000 USD
CY2016Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
722000 USD
CY2015Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
721000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
375000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47661000 USD
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
4331000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1162000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2674000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
156000 USD
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
9190000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8698000 USD
CY2015Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
6923000 USD
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
663000 USD
CY2016Q2 us-gaap Equity Method Investments
EquityMethodInvestments
579000 USD
CY2015Q4 us-gaap Equity Method Investments
EquityMethodInvestments
579000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5734000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1631000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
446000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
353000 USD
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
260000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
93000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
119000 USD
ams Investment In Subsidiaries By Noncontrolling Interests
InvestmentInSubsidiariesByNoncontrollingInterests
7000 USD
CY2015 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
670000 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
226000 USD
CY2015 ams Investment In Subsidiaries By Noncontrolling Interests
InvestmentInSubsidiariesByNoncontrollingInterests
46000 USD
CY2015 us-gaap Profit Loss
ProfitLoss
-576000 USD
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
719000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4020000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1169000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
236000 USD
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
614000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3211000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3404000 USD
CY2015Q4 us-gaap Minority Interest
MinorityInterest
5050000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
10376000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
11000 USD
us-gaap Interest Expense
InterestExpense
665000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
8511000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4164000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59301000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54114000 USD
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25690000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25180000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
20130000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3098000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1400000 USD
us-gaap Gross Profit
GrossProfit
3399000 USD
us-gaap Profit Loss
ProfitLoss
-1405000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
437000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1842000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1912000 USD
us-gaap Interest Expense
InterestExpense
718000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
8756000 USD
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
494000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1479000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
942000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-108000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
157000 USD
us-gaap Profit Loss
ProfitLoss
685000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
541000 USD
us-gaap Net Income Loss
NetIncomeLoss
144000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
979000 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
345000 USD
CY2015Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4394000 USD
CY2015Q2 us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
281000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7401000 USD
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2015Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
718000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
1802000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
478000 USD
CY2015Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
5000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106000 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-1737000 USD
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
233000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-1970000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2016Q2 us-gaap Interest Expense
InterestExpense
433000 USD
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4518000 USD
CY2016Q2 us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
250000 USD
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1649000 USD
CY2016Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
780000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
443000 USD
CY2015Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
262000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3124000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
305000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
213000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3869000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3401000 USD
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-13000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
301000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
268000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5548000 shares
us-gaap Interest Paid
InterestPaid
889000 USD
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-108000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3234000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-6000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
97000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1160000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
176000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
119000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
767000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2059000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2055000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
8780000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
739000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-445000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1059000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1798000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1344000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
575000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-24000 USD
us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-575000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1349000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3271000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1781000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
7000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
27000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
us-gaap Interest Paid
InterestPaid
1066000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5480000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5564000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5480000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5552000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5484000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16000 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5568000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5484000 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
605000 shares
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
119000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
614000 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5368000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5364000 shares
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000 USD
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5368000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5364000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.85
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.86
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
630000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
90000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.19
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.1
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M5D
ams Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P6Y11M5D
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1814000 USD
CY2016Q2 us-gaap Cost Method Investments
CostMethodInvestments
579000 USD
CY2016Q2 ams Assets Carrying Value
AssetsCarryingValue
2393000 USD
CY2015Q4 ams Assets Carrying Value
AssetsCarryingValue
2838000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2259000 USD
CY2015Q4 us-gaap Cost Method Investments
CostMethodInvestments
579000 USD
CY2016Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7588000 USD
CY2015Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
9597000 USD
CY2016Q2 ams Liabilities Carrying Value
LiabilitiesCarryingValue
7588000 USD
CY2015Q4 ams Liabilities Carrying Value
LiabilitiesCarryingValue
9597000 USD
CY2016Q2 ams Restricted Cash And Cash Equivalents Fair Value
RestrictedCashAndCashEquivalentsFairValue
1814000 USD
CY2015Q4 ams Restricted Cash And Cash Equivalents Fair Value
RestrictedCashAndCashEquivalentsFairValue
2259000 USD
CY2016Q2 us-gaap Cost Method Investments Fair Value Disclosure
CostMethodInvestmentsFairValueDisclosure
579000 USD
CY2015Q4 us-gaap Cost Method Investments Fair Value Disclosure
CostMethodInvestmentsFairValueDisclosure
579000 USD
CY2016Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2393000 USD
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2838000 USD
CY2016Q2 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
7662000 USD
CY2015Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
9744000 USD
CY2016Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
7662000 USD
CY2015Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9744000 USD
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1000000 shares
CY2016Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
72000 shares
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
AMERICAN SHARED HOSPITAL SERVICES
dei Entity Central Index Key
EntityCentralIndexKey
0000744825
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
AMS
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5367647 shares
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
94784000 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102683000 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
2679000 USD
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
2592000 USD
us-gaap Cost Of Revenue
CostOfRevenue
5184000 USD
us-gaap Cost Of Revenue
CostOfRevenue
5112000 USD
CY2016Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2015Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
2114000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
2114000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5000 USD
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
58000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94000 USD
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000 USD
us-gaap Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
1023000 USD
us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
1137000 USD
us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
0 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
627000 shares
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P10Y
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26154000 USD
CY2015Q4 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
26000 USD

Files In Submission

Name View Source Status
0001144204-16-118323-index-headers.html Edgar Link pending
0001144204-16-118323-index.html Edgar Link pending
0001144204-16-118323.txt Edgar Link pending
0001144204-16-118323-xbrl.zip Edgar Link pending
ams-20160630.xml Edgar Link completed
ams-20160630.xsd Edgar Link pending
ams-20160630_cal.xml Edgar Link unprocessable
ams-20160630_def.xml Edgar Link unprocessable
ams-20160630_lab.xml Edgar Link unprocessable
ams-20160630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v445336_10q.htm Edgar Link pending
v445336_ex10-1.htm Edgar Link pending
v445336_ex10-1a.htm Edgar Link pending
v445336_ex10-2.htm Edgar Link pending
v445336_ex10-2a.htm Edgar Link pending
v445336_ex10-2b.htm Edgar Link pending
v445336_ex10-3.htm Edgar Link pending
v445336_ex10-3a.htm Edgar Link pending
v445336_ex31-1.htm Edgar Link pending
v445336_ex31-2.htm Edgar Link pending
v445336_ex32-1.htm Edgar Link pending